AAAAAA

   
Results: 1-9 |
Results: 9
Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma
Authors: Butch, AW Badros, A Desikan, KR Munshi, NC
Citation: Aw. Butch et al., Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma, BONE MAR TR, 27(6), 2001, pp. 663-666
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone
Authors: Desikan, KR Tricot, G Munshi, NC Anaissie, E Spoon, D Fassas, A Toor, A Zangari, M Badros, A Morris, C Vesole, DH Siegel, D Jagannath, S Barlogie, B
Citation: Kr. Desikan et al., Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone, BR J HAEM, 112(1), 2001, pp. 242-247
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone
Authors: Desikan, KR Tricot, G Dhodapkar, M Fassas, A Siegel, D Vesole, DH Jagannath, S Singhal, S Mehta, J Spoon, D Anaissie, E Barlogie, B Munshi, N
Citation: Kr. Desikan et al., Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone, BONE MAR TR, 25(5), 2000, pp. 483-487
Clinical experience with thalidomide in multiple myeloma: Phase II trial results in refractory disease and ongoing studies
Authors: Munshi, NC Desikan, KR Barlogie, B
Citation: Nc. Munshi et al., Clinical experience with thalidomide in multiple myeloma: Phase II trial results in refractory disease and ongoing studies, SEM HEMATOL, 37(1), 2000, pp. 15-21
Stem cell transplantation for multiple myeloma - 10 years later
Authors: Siegel, DS Lim, SH Tricot, G Desikan, KR Fassas, A Mehta, J Singhal, S Anaissie, E Jagannath, S Barlogie, B
Citation: Ds. Siegel et al., Stem cell transplantation for multiple myeloma - 10 years later, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 499-516
Lymphomatoid granulomatosis following autologous stem cell transplantation
Authors: Fassas, A Jagannath, S Desikan, KR Shah, HR Shaver, R Waldron, J Munshi, NC Barlogie, B Tricot, G
Citation: A. Fassas et al., Lymphomatoid granulomatosis following autologous stem cell transplantation, BONE MAR TR, 23(1), 1999, pp. 79-81
Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma
Authors: Fassas, ABT Desikan, KR Siegel, D Golper, TA Munshi, NC Barlogie, B Tricot, G
Citation: Abt. Fassas et al., Tumour lysis syndrome complicating high-dose treatment in patients with multiple myeloma, BR J HAEM, 105(4), 1999, pp. 938-941
Age is not a prognostic variable with autotransplants for multiple myeloma
Authors: Siegel, DS Desikan, KR Mehta, J Singhal, S Fassas, A Munshi, N Anaissie, E Naucke, S Ayers, D Spoon, D Vesole, D Tricot, G Barlogie, B
Citation: Ds. Siegel et al., Age is not a prognostic variable with autotransplants for multiple myeloma, BLOOD, 93(1), 1999, pp. 51-54
Total therapy with tandem transplants for newly diagnosed multiple myeloma
Authors: Barlogie, B Jagannath, S Desikan, KR Mattox, S Vesole, D Siegel, D Tricot, G Munshi, N Fassas, A Singhal, S Mehta, J Anaissie, E Dhodapkar, D Naucke, S Cromer, J Sawyer, J Epstein, J Spoon, D Ayers, D Cheson, B Crowley, J
Citation: B. Barlogie et al., Total therapy with tandem transplants for newly diagnosed multiple myeloma, BLOOD, 93(1), 1999, pp. 55-65
Risultati: 1-9 |